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Abstract
Human papillomavirus-16 (HPV-16) genomes in cell culture and in situ are affected by polymorphic methylation patterns, which can repress
the viral transcription. In order to understand some of the underlying mechanisms, we investigated changes of the methylation of HPV-16 DNA in
cell cultures in response to cellular differentiation, to recombination with cellular DNA, and to an inhibitor of methylation. Undifferentiated W12E
cells, derived from a precancerous lesion, contained extrachromosomal HPV-16 DNAwith a sporadically methylated enhancer–promoter segment.
Upon W12E cell differentiation, the viral DNA was demethylated, suggesting a link between differentiation and the epigenetic state of HPV-16
DNA. The viral genomes present in two W12I clones, in which individual copies of the HPV-16 genome have integrated into cellular DNA (type 1
integrants), were unmethylated, akin to that seen in the cervical carcinoma cell line SiHa (also a type 1 integrant). This finding is consistent with
hypomethylation being necessary for continued viral gene expression. In contrast, two of three type 2 integrant W12I clones, containing
concatemers of HPV-16 genomes integrated into the cellular DNA contained hypermethylated viral DNA, as observed in the cervical carcinoma
cell line CaSki (also a type 2 integrant). A third, type 2, W12I clone, interestingly with fewer copies of the viral genome, contained unmethylated
HPV-16 genomes. Epithelial differentiation of W12I clones did not lead to demethylation of chromosomally integrated viral genomes as was seen
for extrachromosomal HPV-16 DNA in W12E clones. Hypomethylation of CaSki cells in the presence of the DNA methylation inhibitor 5-aza-2′-
deoxycytidine reduced the cellular viability, possibly as a consequence of toxic effects of an excess of HPV-16 gene products. Our data support a
model wherein (i) the DNA methylation state of extrachromosomal HPV16 replicons and epithelial differentiation are inversely coupled during the
viral life cycle, (ii) integration of the viral genome into the host chromosome events leads to an alteration in methylation patterns on the viral
genome that is dependent upon the type of integration event and possibly copy number, and (iii) integration universally results in the viral DNA
becoming refractory to changes in methylation state upon cellular differentiation that are observed with extrachromosomal HPV-16 genomes.
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Most cis-responsive elements that modulate the transcription
from the E6 promoter of the human papillomaviruses (HPVs) that
are involved in cervical carcinogenesis are condensed in a
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doi:10.1016/j.virol.2007.12.016the long control region (LCR). This segment contains binding
sites for numerous cellular and viral transcriptional activators and
repressors and for the factors that initiate replication (reviewed in
Bernard, 2002). Transcriptional regulation of these HPVs is very
complex due to the synergies and antagonism between these
elements, and is further complicated since the availability of the
transcription factors varies in different epithelia and different
layers of an epithelium and during different stages of carcinogen-
esis. Beyond the effects of sequence specific factors, gene
regulation is strongly influenced by the chromatin organization of
HPV genomes (Stünkel and Bernard, 1999; Zhao et al., 1999;
293M. Kalantari et al. / Virology 374 (2008) 292–303DelMar-Pena and Laimins, 2001). Just like the chromosomal
DNA of all eukaryotes, HPV DNA is organized in the form of
nucleosomes, which can undergo conformational changes under
the influence of histone acetylation, histone deacetylation, DNA
methylation, and (not yet shown for HPVs) histone methylation
(Stünkel and Bernard, 1999; Zhao et al., 1999; Badal et al., 2003;
Kim et al., 2003; Van Tine et al., 2004; Kalantari et al., 2004;
Wiley et al., 2005; Bhattacharjee and Sengupta, 2006; Balderas-
Loaeza et al., 2007). Chromatin changes can induce or repress
transcription (Bird, 2002; Fuks, 2005; Goll and Bestor, 2005) as
a consequence of a complex regulatory network sometimes
referred to as “epigenetic conversation”. DNAmethylation refers
to the transfer of a methyl group to a cytosine residue, which
is most often part of a CpG dinucleotide. Methylated CpGs
(meCpGs) of cellular DNA and likely also of HPVs are recog-
nized by methylated DNA binding factors such as MeCP2
(Klose et al., 2005), which affect surrounding chromatin due to
their association with histone deacetylases (HDACs). As a
consequence, methylated DNA sequences are normally in a
transcriptionally repressed state.
It has been shown that completely methylated HPV-16 DNA is
transcriptionally inactive (Rösl et al., 1993). Investigation of viral
genomes in situ and in cell culture showed that the CpGs of the
LCR of HPV-16 are very often methylated, but normally in
scattered patterns rather than completely. The average of multiple
clinical samples andmultiple molecules from each sample derived
from carcinomas, precancerous lesions, asymptomatic infections,
and cancer and precancerous cell lines showed methylation rates
of individual CpGs between three and about twenty percent (Badal
et al., 2003; Kim et al., 2003; Kalantari et al., 2004). The conse-
quences of thesemethylation patterns have not yet beenmeasured.
However, one can infer that a single meCpG dinucleotide may
bindmethylatedDNAbinding proteins and therefore likely affects
at least one if not both flanking nucleosomes. Consequently, one
or fewmeCpGs in the LCRofHPV-16 can suffice to target the two
nucleosomes that are specifically positioned on the viral enhancer
and promoter (Stünkel and Bernard, 1999), thereby repressing
early transcription. In relation to the data that we report in this
studywe therefore posit that a singlemeCpGwithin or close to the
HPV-16 enhancer or promoter segments is sufficient to cause
an impairment of early transcription.
The presently available knowledge about HPV-16 genome
methylation was garnered from cellular material sampled atFig. 1. CpGs in the long control region and 3′ end of the L1 gene in HPV-16. The u
genomic segment, the lower part the relative position of the 19 CpG residues addrestatic conditions, namely from the cell lines W12 (Kim et al.,
2003), CaSki and SiHa (Badal et al., 2003; Kalantari et al., 2004)
or from cervical, anal and oral samples (Kalantari et al., 2004;
Wiley et al., 2005; Balderas-Loaeza et al., 2007). We do not yet
have information about the change of methylation in response to
growth conditions in cell culture or changing physiological or
pathological conditions in individual patients over time. The
experiments that led to this publication aimed to understand how
HPV-16 DNAmethylation is affected in cell culture by epithelial
differentiation, chromosomal recombination, and inhibition of
methylation in order to hypothesize and eventually measure how
these events would affect the virus in situ.
Results
Concept of this study
The LCR of HPV-16 is an 850 bp DNA segment between the
genomic nucleotide positions 7154 and 97 flanked on the 5′ end
by the L1 gene and on the 3′ end by the E6 gene. It contains a
transcriptional enhancer with numerous cis-responsive elements
between the positions 7500 and 7820, a replication origin with E1
and E2 binding sites between the nucleotide positions 7860 and
10, a silencer with CDP and YY1 binding sites overlapping with
the replication origin, and a promoter region with four elements
between the nucleotide positions (nts) 27 and 70 (reviewed in
Bernard, 2002). Five CpGs overlap with the enhancer (@ nts
7535, 7554, 7677, 7683, 7689), of which one (@ nts 7862) is part
of an E2 binding site that activates the replication origin, and five
others (@ nts 31, 37, 43. 52, 58) overlap with the promoter, the
first one being within the Sp1 site and the other four positioned
within two E2 binding sites (Tan et al., 1994; Demeret et al.,
1997). It is likely that methylation of a single one of these eleven
CpG sites negatively affects transcription from the E6 promoter
due to predicted effects of methylation on the two nucleosomes
that are specifically positioned over the enhancer and promoter.
The functional consequences of methylation of eight CpGs
overlapping with L1 (@ nts 7091, 7136, 7145) and of the 5′ part
of the LCR (at nts 7270, 7428, 7434, 7455, 7461) are unknown.
Interestingly, nucleotide positions 7455 and 7461 are part of anE2
binding site, whose function is not well understood. Fig. 1 shows
landmarks of the HPV-16 LCR and the position of all 19 CpGs
that we investigated.pper part of the figure summarizes the functional and topologic elements of this
ssed by our study.
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genomes. Because we learned in our previous research that each
of these genomes may be affected differently by DNA methyl-
ation, we standardized our analyses by cloning and sequencing
ten to 16 HPV-16 amplimer molecules after bisulfite modifica-
tion, PCR amplification, and cloning into E. coli vectors. We
report the data from these experiments graphically as introduced
previously (Kalantari et al., 2004) and presented in the figures
of this paper. Vertically arranged rectangles refer to the CpGs in
a specific genomic position and horizontally arranged rectan-
gles to the CpGs in different amplicons. White rectangles
identify unmethylated and black rectangles methylated CpGs.
Since the whole region of interest within the HPV-16 genome
cannot be amplified in the form of a single amplicon due to
covalent cleavage of DNA by bisulfite, each horizontal line of
rectangles represents three independent amplicons, which had
originally not been contiguous.
Methylation of episomal HPV-16 DNA in W12 cell cultures
W12 cells were derived from a precancerous lesion (Stanley
et al., 1989) and contain about 1000 extrachromosomal HPV-16
genomes, as measured in two subclones (20850 and 20863)
established previously (Jeon et al., 1995; Jeon and Lambert,
1995). Fig. 2A shows that six out of 16 clones of HPV-16 clones
from 20850 and eight out of 16 clones from 20863 contained
one or two meCpGs, respectively, overlapping with the viral
enhancer or promoter (average methylation rate for each CpG
4.0 and 7.4%, respectively). This is a very low rate of
methylation, but it nevertheless suggests that a third to a half
of all HPV-16 genomes in W12 cells may be partially or com-Fig. 2. Methylation of a genomic segment of HPV-16 including the whole long
differentiated W12 cells with episomal viral copies. A: W12 clone 20850; B: W12
dinucleotides, the number on the top of the bar the position of this CpG in the genome
HPV-16 genome, covering the 3′ end of the L1 gene and the complete long control reg
ones. The two vertical white separators indicate the borders between amplicons, and d
the left side of the figure identify the W12 subclone. Diff: differentiated cells, undifpletely transcriptionally repressed due to epigenetic effects.
Methylation was much higher in the L1 segment and the 5′
LCR, with 17 and 58 meCpGs, respectively, out of 128 potential
CpG targets (13.3 and 45.3%). The reason for this difference is
not known, as prior analyses did not detect important biological
differences between these two clones, and may not be of
consequence since this region of the viral genome is not
expressed until differentiation occurs (see below).
Demethylation of episomal HPV-16 DNA in W12 cells in
response to differentiation
Prior studies had demonstrated that treatment of W12E cells
with high concentrations of calcium ions and serum at confluent
growth results in their terminal differentiation, as judged by the
induction of Keratin 10 expression, and the formation of strat-
ified epithelium with the appearance of keratin bundles, nuclear
condensation and virus like particles in the more superficial
layers (Flores and Lambert, 1997). We confirmed that we could
recapitulate this induction of differentiation of W12E cells using
the same culture conditions by monitoring for the expression of
differentiation markers (Fig. 3). Fig. 2B shows that the HPV-16
genomes in the clones 20850 and 20863 lost all cytosine
methylation in the enhancer and promoter segment in response
to this differentiation protocol. Only four meCpGs were main-
tained in the L1/5′ LCR segment of clone 20850. This finding
of hypomethylation in HPV-16 replicons in differentiated
W12E cells is consistent with our prior data analyzing differ-
entiated subfractions of W12E cells isolated by elutriation (Kim
et al., 2003). That the L1 region becomes unmethylated might
be of importance since this L1, which encodes the major capsidcontrol region (LCR) and a segment of the L1 gene in undifferentiated and
clone 20863. Each vertical set of rectangles represents one of 19 specific CpG
of HPV-16. Each horizontal set of rectangles represents a 913 bp segment of the
ion. Unmethylated CpGs are indicated by white rectangles, methylated by black
iscontinuities between supposedly different HPV-16 molecules. The numbers on
f: undifferentiated cells.
Fig. 3. Induction of epithelial differentiation. Shown are Western blots demonstrating the induction of the expression of involucrin, a marker for epithelial cell
differentiation of stratified squamous epithelia, in those cells grown in high calcium/high serum. Also shown are control, beta-actin-specific Western blots
demonstrating that equal amounts of total cellular protein were loaded. Note induction in the levels of involucrin in cells cultured in the presence of high calcium and
high serum.
295M. Kalantari et al. / Virology 374 (2008) 292–303protein, is induced in its expression during terminal differentia-
tion allowing for the production of progeny virions.
Demethylation of HPV-16 DNA in W12 clones in response to
chromosomal integration of individual viral genomes
The clones 20822 and 201402 were derived from W12 cells
during culture in vitro. They have lost all extrachromosomal
HPV-16 DNA replicons, but maintained three and five HPV-16
genomes, respectively, that have recombined with cellular DNA
as single genomic copies that had then subsequently underwent
amplification along with neighboring DNA (i.e. type 1 inte-
grated clones) (Jeon et al., 1995; Jeon and Lambert, 1995).
Fig. 4 shows that these integrated viral DNA genomes are
unmethylated in both cell clones within the enhancer and pro-
moter segments, as 16 and ten E. coli clones, respectively, did
not contain a single meCpG dinucleotide. A rudimentary level
of methylation is maintained in the L1–5′ LCR region (7 and
5%, respectively). This outcome resembles the methylation state
of HPV-16 in the carcinoma derived SiHa cells, also containing a
type 1 integration event, whose LCR is unmethylated, while L1
is hypermethylated (Badal et al., 2003; Kalantari et al., 2004).
Multiple, tandemly integrated HPV-16 genomes became
hypermethylated in two and unmethylated in one W12
derivative
In contrast to the two W12 type 1 integrant clones, the clones
20831, 20862, and 20861 contain numerous integrated HPV-16
genomes, all or the majority of which are arranged as tandem or
concatemeric repeats (type 2 integration). Quantitative Southern
blots led to estimates of 60, 60, and 30 HPV-16 DNA copies in
these three clones, respectively (Jeon et al., 1995; Jeon and
Lambert, 1995). Fig. 4 shows that the viral DNA genomes
present in clones 20831 and 20862 were hypermethylated in the
enhancer–promoter segment (42 [23.9%] and 62 [35.2%]
meCpGs, respectively, of 176 potential CpG targets) as well
as in the L1–5′ LCR segment (39 [30.5%] and 38 [29.7%]meCpGs among 128 potential CpG targets). This outcome
resembles the situation observed in many cervical cancers and
in the cervical carcinoma derived CaSki cell line that harbors
type 2 integrated HPV DNAs, in which most of the 500 con-
catemeric HPV-16 genomes are hypermethylated in the LCR
and L1. In contrast, in clone 20861 only a single one of 16 HPV-
16 copies contained three meCpGs, and five of 16 clones
contained single meCpGs in the L1 gene. The rest of the DNA
analyzed from clone 20861 was hypomethylated. A similar
outcome had been observed in the analysis of a small fraction of
cancer samples that we studied (Badal et al., 2003; Kalantari
et al., 2004). Interestingly, clone 20861 containing mostly
unmethylated HPV-16 genomes expresses the viral E6 and E7
oncoproteins and E6/E7 mRNAs at the highest levels even
though, among the type 2 integrants, it has the fewest copies of
the viral genome (Jeon et al., 1995; Jeon and Lambert, 1995;
Shai et al., 2007).
Methylation of integrated HPV-16 genomes does not change in
response to differentiation
We observed that extrachromosomal HPV-16 genomes
become hypomethylated in differentiated W12E cells (Fig. 2B;
also see Kim et al., 2003). To address the question whether
cellular differentiation also influences the methylation status of
integrated HPV-16 genomes, we exposed all fiveW12I clones to
differentiation promoting culture conditions. All W12I clones
underwent differentiation as judged by the induction in
expression of differentiation markers (Fig. 3). This is consistent
with our prior findings that W12I clones are susceptible to
differentiation, to a degree similar to that of W12E clones (Jeon
et al., 1995). The two type 1 integrant W12I clones with hypo-
methylated sequences (20822, 201402) remained unmethylated
in the LCR and hypomethylated in L1 (Fig. 4), similar to the type
2 integrant 20861, which remained hypomethylated in the LCR,
and even showed a slight increase of methylation in L1. More
interestingly, the hypermethylated state of the viral DNA
observed in the W12I clones 20862 and 20831 was not reduced
Fig. 4. Methylation of a genomic segment of HPV-16 including the LCR and a segment of the L1 gene in undifferentiated and differentiated W12 clones with
chromosomally integrated HPV-16 genomes. A: individual HPV-16 genomes integrated into the chromosomal DNA (type 1 integrants); B: concatemeric HPV-16
genomes integrated into the chromosomal DNA (type 2 integrants). The notation system of the data is explained in detail in the legend to Fig. 1.
296 M. Kalantari et al. / Virology 374 (2008) 292–303upon their growth in differentiating culture conditions (i.e.
methylation throughout the 19 CpG studied here), as the
methylation rate was 32.9% in 20862 and 26.6% in 20831 before
differentiation, and 35.8% and 38.4%, respectively, afterwards.
We measured the levels of E6/E7 transcripts during the
course of all differentiation experiments by real-time PCR.
Surprisingly, we observed a slight decrease of transcription,
which was, however, also reflected in the decreased transcrip-tion of a cellular control gene (Fig. 5). This was observed for
multiple clones of W12 cells including the W12E clone 20850
wherein the viral DNA becomes hypomethylated upon differ-
entiation. The fact that the transcripts are less abundant in the
terminally differentiated W12E cells is consistent with pre-
viously published studies on E7 by Western blotting in raft
cultures of cells harboring extrachromosomal DNA (Collins
et al., 2005). This does not provide evidence against
Fig. 5. Transcription of HPV-16 E6 and E7 and, as control, the cellular ribosomal protein S9 as measured by RT-PCR. Left columns of each pair: undifferentiated cells;
right column: differentiated cells. The data suggest a general reduction of transcriptional activity in response to epithelial differentiation and do not allow measuring the
expected transcriptional induction of clone 20850 due to demethylation.
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298 M. Kalantari et al. / Virology 374 (2008) 292–303derepression of HPV transcription by demethylation, but more
likely points to a general reduction of transcriptional activity
during epithelial differentiation and/or the sequestration of
amplified viral DNA in capsids in the terminally differentiated
cells.
5-aza-2′-deoxycytidine reduces the methylation of HPV-16
genomes and the viability of the tumor cell line CaSki
The phenotypic consequences of HPV-16 DNA methylation
and demethylation during the productive viral life cycle and
during carcinogenesis are not yet known. To begin to under-
stand the consequences of demethylation of HPV-16 genomes
in a tumor cell line, we investigated the response of CaSki cells
to treatment with the DNA methylation inhibitor 5-aza-2′-
deoxycytidine (5-Aza-CdR). CaSki cells contain about 500
HPV-16 genomes, which are hypermethylated (Kalantari et al.,
2004) with the consequence that all of these viral genomes
except one copy are transcriptionally silent (Van Tine et al.,
2004).
As a baseline, we confirmed previous data that the LCR and
L1 of most HPV-16 copies in CaSki is hypermethylated, with
108 meCpGs out of a total of 152 target CpGs (71.1%). Growth
of the cells in the presence of 5 μM 5-Aza-CdR for 72 h reduced
methylation in these segments to 27.6% (42 out of 152) (Fig. 6).
Some of the enhancer and promoter clones from the 5-Aza-CdR-
treated CaSki cells were completely demethylated, although a
demethylation of contiguous enhancer–promoter segments
cannot be confirmed as the enhancer and promoter clones were
derived from random different HPV-16 template DNAs present
in the extracted DNA from CaSki cells.
Wemeasured the levels of E6/E7 transcripts during the course
of these experiments by real-time PCR, but did not detect
obvious changes (data not shown). This does not provide
evidence against release of repression by demethylation, as the
increased activity of some few demethylated HPV-16 genomes
on a background of an excess of continuously repressed methyl-
ated genomes may not lead to a measurable difference in signal.Fig. 6. Methylation changes of a genomic segment of HPV-16 including the LCR
5-deoxy-2′azacytidine. The notation system of the data is explained in detail inGrowth of CaSki cells under the influence of 5-Aza-CdR
slowed down after five days and completely stopped in the
second week of treatment, combined with physical changes of
the cells (flat growth, development of cytoplasmic extensions,
high transparency), indicating stress or death of these cells. This
may relate to the derepression of HPV-16, since the growth and
physical properties of SiHa cells, which have a single
unmethylated HPV-16 genome (Kalantari et al., 2004) and
HeLa cells, which have about 50, mostly unmethylated HPV-18
genomes (Turan et al., 2006 and 2007) were not affected in their
growth or physical properties by treatment with 5-Aza-CdR
(data not shown).
Discussion
Extrachromosomal HPV-16 genomes are subject to
differentiation specific methylation and demethylation
We report that extrachromosomal HPV-16 DNA in the W12
clones 20850 and 20863 is targeted by scattered and quanti-
tatively moderate DNA methylation as long as these cells are
cultured such that they resemble the undifferentiated basal epi-
thelial layer. In response to differentiation, methylation is lost.
These observations support previous data from the lab of one of
us that elutriation of W12 cultures separates small, undiffer-
entiated cells, which have mostly methylated HPV-16 genomes,
from large, differentiated cells with mostly unmethylated viral
DNA (Kim et al., 2003). These cell culture data may also
explain correlations observed in the study of clinical samples.
Methylation of HPV-16 in asymptomatic infections was found
to exceed the methylation of HPV-16 in precancerous lesions,
most likely since asymptomatic infections contain many HPV-
16 genomes in undifferentiated cells, possibly in a state of
latency, while most HPV-16 genomes in lesions may exist in
suprabasal cells (Kalantari et al., 2004). The underlying mech-
anism for differentiation linked methylation and demethylation is
presently not known. One possibility is that the sequence specific
factors CDP and YY1, which bind HPV silencers (O'Connorand a segment of the L1 gene in CaSki cells in response to treatment with
the legend to Fig. 1.
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et al., 1997; Ai et al., 2000) may trigger a cascade of histone
methylation (Rezai-Zadeh et al., 2003; Nishio and Walsh, 2004)
and de novo DNA methylation (Fuks, 2005). The high concen-
tration of CDP and YY1 in undifferentiated cells and the binding
of these factors to HPV-16 genomes may therefore be the primary
trigger to induce methylation, and loss of these two factors may
result in demethylation during subsequent rounds of replication
in differentiating cells. This proposed mechanism would add
another pathway to explain how epithelial differentiation and
transcription of HPVs are linked beyond the previously disco-
vered coupling of AP-1, CDP and YY1 with histone acetylases
and deacetylases (reviewed in Bernard, 2002). Alternatively, one
can propose that as extrachromosomal viral replicons undergo
amplification in differentiating cells (a pre-requisite for progeny
virus production), these amplified viral DNAgenomesmay not be
subject to methylation owing to an absence of DNMT activity in
differentiated cells, titration of DNMTor other components of the
methylation machinery due to increased copies of the viral DNA,
or the sequestration of newly synthesized viral genomes from the
methylation apparatus, for example, by their encapsidation into
virions. With the method used for inducing differentiation in this
study, i.e. culturing the cells in high calcium and high serum, we
have previously documented the accumulation of progeny virions
(Flores and Lambert, 1997).
DNA methylation is known to repress cellular genes (Bird,
2002) and genes of some viruses (Robertson, 2000) by two
different mechanisms, namely through the effect of methylated
DNA binding proteins and associated HDACs on the chromatin
structure, and due to the interference of meCs with the binding
of certain transcription factors. There are presently at least three
lines of evidence that DNA methylation affects the transcription
of HPV genes in undifferentiated cells by these mechanisms,
namely the lack of transcription of in vitro methylated HPV-16
genomes after transfection into cell cultures (Rösl et al., 1993),
the repression of hypermethylated HPV-16 genomes in CaSki
cells (Badal et al., 2003; Van Tine et al., 2004; Kalantari et al.,
2004), and the interference of CpG methylation with the
binding of the papillomavirus transcription factor E2 (Thain
et al., 1996; Kim et al., 2003). It is therefore concluded that
documentation of HPV-16 DNA methylation in cell culture and
in clinical samples can be used as a tool to infer the transcrip-
tional modulation of HPV-16 in vivo. Transcriptional mo-
dulation could not be detected in our study wherein we induced
the differentiation of cells, most likely because the hypomethy-
lated, amplified genomes in these cells get packaged into virions
and therefore are sequestered from further transcription (see
above).
The methylation state of integrated HPV-16 genomes is
established as a consequence of the recombination event
Continued expression of the oncoproteins E6 and E7 is
required for continued growth of HPVassociated neoplasia and
cell cultures derived from such lesions (Francis et al., 2000).
Consequently, it is not surprising that the LCR of the one or
two HPV-16 genomes of SiHa cells lacks any meCpGs (Badalet al., 2003; Kalantari et al., 2004) in the same way as the few
viral genomes of the W12 clones 20822 and 201402, all of
which have type 1 integration events.While HPV-16 DNA in the
precursors of these cell lines may have been amethylation target,
it is reasonable to hypothesize that cells in which recombination
between viral and chromosomal DNA resulted in methylated
HPV-16 genomes would have lacked the oncoprotein dependent
growth advantage and were therefore eliminated.
CaSki cells are a vivid example for the need for continued E6
and E7 expression, as all 500 HPV-16 genomes, recombined
with different cellular loci, were targeted and repressed by DNA
methylation except for a single viral copy at the junction be-
tween a viral concatemer and host DNA, which continues to
transcribe the oncoproteins (Kalantari et al., 2004; Van Tine
et al., 2004). Similar to the situation in CaSki, HPV-16 DNAwas
found to be largely hypermethylated in the W12 clones 20831
and 20862, but unmethylated in clone 20861. The differential
outcome of these recombination events may be a consequence of
flanking cellular DNA sequences, a heterochromatic environ-
ment favoring methylation, a euchromatic environment lack of
methylation (Doerfler et al., 2001). The decision between
methylation of DNA and lack of methylation may also be
affected by the activity of nuclear matrix attachment regions,
known antagonists of DNAmethylation (Stünkel et al., 2000), or
the recognition of tandem repeats as genomic parasites (Yoder
et al., 1997; Goll and Bestor, 2005). In the clones 20831 and
20862 with methylated HPV-16 genomes, unmethylated en-
hancer and promoter segments (Fig. 4) among the multiple HPV-
16 genomes are likely contiguous at least in some viral genomes,
and provide for the continued expression of E6 and E7 (Jeon
et al., 1995; Jeon and Lambert, 1995).
The tandem arrangement of viral DNA present in type 2
integrants alone does not suffice to establish a methylation
target, as clone 20861 contains multiple concatemeric HPV-16
genomes, all of which remained unmethylated. 20861 has a
tenfold higher E6/E7 expression level than 20831 and 20862,
although only half as many HPV-16 genome copies (Jeon et al.,
1995; Jeon and Lambert, 1995). These previous studies also
demonstrated that most of the transcripts stably accumulating in
all of the type 2 integrant clonal populations of W12 cells come
from the integration-disrupted junction copy(s) of the viral
genome. The observation that the vast majority of copies of the
viral genome are unmethylated and should therefore be tran-
scriptionally active can be reconciled with the previous finding
by there being a selective increased stability of the mRNAs
arising from the junction copy (as postulated by Jeon et al., 1995;
Jeon and Lambert, 1995).
HPV-16 genomes conform to other types of chromosomally
integrated foreign DNA, which are known methylation targets
in a variety of systems ranging from transgenic animals, knock-
out clones, retrovirus and adenovirus integrations (Doerfler
et al., 2001). In clinical samples, HPV-16 and HPV-18 DNA
have frequently been found chromosomally integrated in cancer
(Schwarz et al., 1985; Daniel et al., 1997; Kalantari et al., 2001;
Luft et al., 2001; Hudelist et al., 2004; Arias-Pulido et al.,
2006). Consequently, HPV-16 DNA methylation may be a
normal part of cancer progression and may affect all those HPV
300 M. Kalantari et al. / Virology 374 (2008) 292–303genome copies that are not required to maintain the transformed
state. Methylated HPV-16 DNA, particularly in the L1 gene,
may actually be used to diagnose progression, as proposed for
HPV-18 (Turan et al., 2006; Turan et al., 2007).
Differentiation does not alter the methylation of HPV-16
genomes that are tandemly integrated into chromosomal DNA
In contrast to the W12E clones 20850 and 20863 with
extrachromosomal HPV-16 DNA replicons, cellular differentia-
tion did not lead to a loss of methylation in the W12I clones
20831 and 20862. Themost likely explanation for this difference
would be that the mechanism for the establishment of
methylation of chromosomally integrated DNA is fundamen-
tally different from the mechanisms affecting extrachromosomal
viral DNAs, resulting in a failure to abrogate methylation during
differentiation in the same way as it happens to extrachromo-
somal copies of the viral genome. This could result if the pos-
sible heterochromatic environment of these recombinant virus
genomes is the primary source of methylation rather than the
activity of CDP and YY1 as outlined above.
The effect of 5-Aza-CdR on HPV-16 methylation
5-Aza-CdR reduces DNA methylation, as this compound
forms covalent complexes with the maintenance DNA methyl
transferase DNMT1, thereby inducing elimination of this
enzymatic activity (Bird, 2002). We reproducibly observed
that CaSki cells lost viability under the influence of 5-Aza-CdR
concomitant with reduction, but not complete elimination of
HPV-16 DNA methylation. Loss of viability may be a result of
the demethylation and transcriptional activation of HPV-16, as
5-Aza-CdR did not show any inhibitory effect on SiHa (with a
single unmethylated HPV-16 genome) and HeLa cells (with
multiple unmethylated HPV-18 genomes). One possible expla-
nation would be that extremely high concentrations of HPV
gene products (exceeding those observed in the 20861 clone)
could be toxic to the host cell. This explanation would require
that many HPV-16 genomes become demethylated in some, but
not simultaneously in all cells, as we could not detect complete
demethylation nor transcriptional induction of the whole 5-Aza-
CdR treated cell population. Alternatively, strong expression of
normally silenced, hypermethylated cellular genes may induce
this cytotoxicity, perhaps in combination with increased viral
gene expression. That the type 2 integrated W12I clone, 20861,
which has hypomethylated HPV-16 genomes and high level E6/
E7 expression is also sensitive to 5-Aza-CdR mediated growth
suppression (data not shown) argues that demethylation of one
or more cellular genes is driving the growth suppression. Under
our cell culture conditions, we could not reproduce the 5-Aza-
CdR dependent transcriptional induction described by others
(Van Tine et al., 2004). In that prior study, the investigators
found by FISH, that this observed transcriptional induction only
arose in a minority of Aza-C treated CaSki cells, perhaps
explaining why we did not observe it in our population based
RT-PCR based quantification. Like in our study the prior study
also noted cytotoxicity in 5-Aza-CdR treated CaSki cells.Conclusions and open questions
HPV-16 genomes are targeted in cervical cells and cell lines
by at least two different mechanisms: (i) Extrachromosomal
viral DNA replicating in undifferentiated cells is moderately
methylated throughout the enhancer–promoter segment, and
this methylation is lost upon differentiation. We think that a
cascade of epigenetic conversation starting with the factors
CDP and YY1 that are abundant in undifferentiated cells and
bind HPV-16 DNA may explain this type of methylation, and
methylation would be eliminated by replication subsequent to
disappearance of CDP and YY1 in differentiated cells. Future
research has to address the exact nature of all components that
participate in this epigenetic regulation, and the questions
whether this mechanism is cell type specific (e.g. takes place
in the foreskin in a similar way as in the cervical mucosa).
(ii) Upon linearization of the HPV-16 genome and recombina-
tion with chromosomal DNA, methylation may target the viral
DNA in a similar way as any type of external DNA irrespective
of its genetic content through effects from flanking heterochro-
matic and euchromatic sequences. In addition, the linearization
of the viral DNA uncouples transcriptional regulation of viral
L1 gene 5′ from the LCR from the influence of the viral
enhancer and promoters. The ensuing lack of transcription may
further stimulate methylation. As a consequence, the diagnosis
of L1 methylation is likely a powerful biomarker of carcino-
genic progression, independent of its role in the context of the
viral life cycle, and will be evaluated in clinical studies.
Materials and methods
Origin and culture of W12 cells and its derivatives
W12 cells have been derived from a cervical intraepithelial
neoplasia (Stanley et al., 1989) and contain approximately 1000
intact extrachromosomal HPV-16 genome copies per cell. The
laboratory of one of us (P.F.L.) established two W12 subclones
(termed 20850 and 20863, and commonly referred to as W12E
clones) that have retained a high copy number of extrachromo-
somal HPV-16 genomes. In two other clones (20822 and
201402, referred to as W12I clones with type 1 integration
pattern), three and five HPV-16 genomes were found recom-
bined with the cellular DNA. In Southern blot analyses, these
clones did not exhibit full-length HPV-16 DNA after cleavage
with restriction enzymes with unique sites in the viral genome,
but rather only junction fragments, likely due to individual
integration of all viral genomes, reminiscent of the carcinoma
derived cell line SiHa with one or two HPV-16 genomes (Baker
et al., 1987; O'Leary et al., 1994). These clones had been
referred to as type 1 integrants. Yet three other W12l clones
(20831, 20861, and 20862) with 30–60 recombined viral
genomes contained full-length viral genomes as well as junction
fragments, similar to the carcinoma derived cell line CaSki
with 500 HPV-16 genomes (referred to as type 2 integrants)
(Jeon and Lambert, 1995).
For maintenance in an undifferentiated state, all seven
W12 clones were maintained below confluence on mitomycin
301M. Kalantari et al. / Virology 374 (2008) 292–303C-treated J2 3T3 feeder cells in F medium (0.66 mM Ca2+)
composed of three parts F-12 medium and one part Dulbecco's
modified Eagle's medium supplemented with 5% fetal bovine
serum (FBS), insulin (5 μg/ml), cholera toxin (8.4 ng/ml),
adenine (24 μg/ml), epidermal growth factor (10 ng/ml) and
hydrocortisone (0.4 μg/ml).
In order to induce epithelial differentiation (Flores and
Lambert, 1997), the W12 clones were grown to confluence on
J2 3T3 feeder cells in F medium (0.66 mM Ca2+), and then
maintained in F medium containing 1.2 mM Ca2+ and 20% FBS
for 2–10 days. Cells were removed from dishes by treatment
with 0.1% trypsin–0.5 mM EDTA, and DNA was prepared by
standard procedures. These conditions induce stratification and
differentiation of W12 cells (Flores and Lambert, 1997).
Growth of CaSki cells in the presence of azacytidine
CaSki cells were grown in DME with 10% FBS in the
absence and presence of 5-aza-2′-deoxycytidine (5-Aza-CdR) at
concentrations of 1 and 5 μM for three and five days, respec-
tively, followed by DNA preparation by standard procedures.
Bisulfite modification
For bisulfite modification (Frommer et al., 1992), 50–1000 ng
of sampleDNA supplementedwith 1μg of salmon spermDNA in
a total volume of 18 μl in water were denatured with 2 μl of 3 M
NaOH and incubated at 37 °C.After denaturation, 278μl of 4.8M
sodium bisulfite and 2 μl of 100 mM hydroquinone were added.
In some experiments, we used a bisulfite kit supplied by Zymo
Research Inc. (EZ bisulfite modification kit). Controls showed
identical experimental outcome whether this kit or our own
reagentswere used. Themixturewas incubated in a thermal cycler
for 20 cycles of 15 min at 55 °C and 30 s at 95 °C. The modified
DNAwas desalted with the QIAquick PCR purification protocol
and desulfonated thereafter by adding 5.5 μl of 3 M NaOH and
5 μg glycogen prior to 15 min incubation at 37 °C. The DNA
was precipitated with 5.6 μl of 3 M sodium acetate and 150 μl of
100% ethanol, followed by centrifugation. The pellet was washed
with 70% ethanol and dissolved in 30–50 μl TE buffer (10 mM
Tris–HCl pH 8, 1 mM EDTA).
Polymerase chain reactions, primers, T/A cloning and DNA
sequencing
The modified DNA was amplified in the form of three
amplicons: Part of the L1 gene and the 5′ LCR with the primers
16msp3F (position 7049–7078, AAGTAGGATTGAAGGT-
TAAATTAAAATTTA) and 16msp3r (position 7590–7560,
AACAAACAATACAAATCAAAAAAACAAAAA); the HPV-
16 enhancer with the primers 16msp4F (position 7465–7493,
TATGTTTTTTGGTATAAAATGTGTTTTT) and 16msp7R
(position 7732–7703, TAAATTAATTAAAACAAACCAAAA-
ATATAT); and the HPV-16 promoter with the primers 16msp5F
(position 7748–7777, TAAGGTTTAAATTTTTAAGGTTAA-
TTAAAT) and 16msp8R (position 115–86, ATCCTAAAACAT-
TACAATTCTCTTTTAATA). The sequences of the primers weredesigned according to the genomic sequence of HPV-16
assuming conversion of all cytosine residues into uracils. PCR
was carried out in a 25 μl volume containing 0.2 mM of each of
the four dNTPs, 10 pmol of the primers, 2 mMMgCl2 and 1 U of
Ampli Taq Gold (Perkin-Elmer). The PCR started at 94 °C for
1 min, followed by 40 amplification cycles (denaturing at 94 °C
for 10 s, annealing at 58 °C for 30 s and extension at 68 °C for
1 min) with final extension at 68 °C for 7 min. The presence of
PCR products was verified by agarose gel electrophoresis, and
confirmed amplicons were cloned with the TOPO TA cloning kit
for sequencing (Invitrogen). Cloned DNAs were sequenced
by Big Dye terminator v3.1 Cycle Sequencing (Applied
Biosystems).
Quantification of RNA
Real-time RT-PCR followedWang-Johanning and Johanning,
2005, with primers to detect HPV-16 E6 (nts 99–178) (Forward
primer: CTGCAATGTTTCAGGACCCA; reverse primer: TC-
ATGTATAGTTGTTTGCAGCTCTGT; probe: FAM-AGGAG-
CGACCCGGAAAGTTACCACAGTT-BHQ), HPV-16 E7 (nts
739–816) (forward primer: AAGTGTGACTCTACGCTTCGG-
TT; reverse primer: GCCCATTAACAGGTCTTCCAAA; probe:
FAM-TGCGTACAAAGCACACACGTAGACATTCGTA-
BHQ), and as a control the human ribosomal protein S9 (nts 419–
504) (forward primer: ATCCGCCAGCGCCATA; reverse primer:
TCAATGTGCTTCTGGGAATCC; probe: FAM-AGCAGGTG-
GTGAACATCCCGTCCTT-TAMRA).
200 pg total RNA was reverse transcribed and amplified
using the TaqMan 1-step RT-PCR kit (Applied Biosystems) in a
total volume of 25 μl containing 100 nM of each forward and
each reverse primer and 150 nM of E6 or E7 TaqMan probe.
Reverse transcription and thermal cycling conditions were
30 min at 48 °C followed by 10 min at 95 °C and 40 cycles of
15 s at 95 °C and 1 min at 60 °C. A negative control excluding
the reverse transcription was run for each reaction by excluding
the MultiScribe enzyme mix. Human ribosomal protein S9
primers and probe were used for normalization of the reactions
and as control for RNA integrity. The reactions were quantified
with an ABIprism 7900HT instrument and the results were
analyzed using AbiPrism's SDS v2.1 software.
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